◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › K › KIDS

Orthopediatrics Corp (KIDS) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-11-04

Orthopediatrics Corp (KIDS) operates in the MEDICAL DEVICES industry and is headquartered in Warsaw, United States with about 602 employees. Its market capitalization is roughly $820 million. In the fiscal year ended 2025-12-31, KIDS reported $236M in revenue and ($40M) in net income.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Interactive charts & full statements → Open the KIDS valuation workbench →

KIDS Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31
Total Revenue	$265M	$236M	$205M	$149M	$122M	$98M	$71M	$73M	$58M	$46M	$37M	$31M	$24M
Gross Profit	$194M	$173M	$149M	$111M	$91M	$73M	$55M	$55M	$43M	$34M	$26M	$22M	$17M
Gross Margin %	73.2%	73.0%	72.6%	74.8%	74.1%	74.9%	77.4%	75.3%	74.2%	75.5%	70.7%	69.8%	70.1%
Operating Income (EBIT)	($22M)	($29M)	($30M)	($27M)	($25M)	($18M)	($27M)	($9M)	($10M)	($6M)	($6M)	($7M)	($7M)
Operating Margin %	-8.3%	-12.3%	-14.4%	-18.0%	-20.8%	-18.4%	-37.6%	-12.5%	-16.6%	-14.2%	-16.4%	-21.3%	-30.2%
Net Income	($34M)	($40M)	($38M)	($21M)	$1M	($16M)	($33M)	($14M)	($12M)	($9M)	($7M)	($8M)	($10M)
Net Margin %	-12.8%	-16.8%	-18.5%	-14.1%	1.0%	-16.6%	-46.4%	-18.9%	-20.9%	-19.6%	-17.6%	-25.4%	-40.3%
EBITDA	—	($12M)	($20M)	($8M)	($9M)	($7M)	($22M)	($5M)	($7M)	($4M)	($3M)	($5M)	($6M)
Earnings Per Share (EPS)	$-1.43	$-1.69	$-1.64	$-0.92	$0.06	$-0.84	$-1.82	$-0.94	$-0.96	$-1.85	$-0.87	$-1.05	$-1.28
Shares Outstanding (M)	—	23M	23M	23M	21M	19M	18M	15M	13M	5M	8M	8M	7M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KIDS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$73M	$71M	$59M	$62M	$61M	$61M	$52M	$53M	$55M
Gross Profit	$54M	$52M	$43M	$45M	$45M	$44M	$38M	$36M	$40M
Gross Margin %	74.0%	74.3%	73.1%	73.2%	73.9%	72.1%	73.0%	67.5%	73.4%
Operating Income (EBIT)	($4M)	($4M)	($8M)	($6M)	($5M)	($11M)	($11M)	($14M)	($6M)
Operating Margin %	-5.5%	-5.8%	-14.0%	-8.9%	-7.9%	-17.4%	-20.9%	-26.7%	-10.2%
Net Income	($6M)	($7M)	($11M)	($10M)	($12M)	($7M)	($11M)	($16M)	($8M)
Net Margin %	-8.2%	-10.2%	-18.0%	-16.4%	-19.2%	-11.7%	-20.3%	-30.5%	-14.5%
EBITDA	—	($4M)	($3M)	$2M	($5M)	($1M)	($4M)	($5M)	($3M)
Earnings Per Share (EPS)	$-0.25	$-0.30	$-0.45	$-0.43	$-0.50	$-0.30	$-0.46	$-0.69	$-0.34
Shares Outstanding (M)	—	24M	24M	24M	23M	23M	23M	23M	23M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KIDS Free Cash Flow History

Cash flow	TTM → 2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31
Cash from Operations (CFO)	$12M	($5M)	($27M)	($27M)	($22M)	($13M)	($19M)	($18M)	($16M)	($7M)	($1M)	($1M)	($10M)
Capital Expenditures (CapEx)	$10M	$11M	$14M	$19M	$10M	$16M	$11M	$12M	$5M	$7M	$5M	$2M	$3M
Free Cash Flow (FCF)	$4M	($16M)	($41M)	($46M)	($32M)	($29M)	($30M)	($30M)	($21M)	($14M)	($6M)	($3M)	($13M)
FCF Margin %	1.5%	-6.8%	-20.2%	-30.9%	-26.0%	-29.6%	-42.0%	-41.1%	-36.6%	-30.2%	-15.8%	-10.1%	-55.9%
Dividends Paid	—	—	—	—	—	—	—	$0M	$0M	$6M	$6M	$6M	$6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KIDS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$4M	$1M	($3M)	$10M	($1M)	($10M)	($4M)	($4M)	($10M)
Capital Expenditures (CapEx)	$3M	$4M	$2M	$1M	$3M	$3M	$4M	$0M	$1M
Free Cash Flow (FCF)	$2M	($3M)	($5M)	$10M	($3M)	($14M)	($8M)	($4M)	($12M)
FCF Margin %	2.7%	-4.4%	-8.5%	15.8%	-5.6%	-22.8%	-16.0%	-8.1%	-21.4%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KIDS Balance Sheet History

Balance sheet	2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31
Total Assets	$509M	$509M	$473M	$439M	$428M	$308M	$325M	$195M	$112M	$82M	$31M	$31M	$36M
Cash & Cash Equivalents	$17M	$20M	$44M	$31M	$9M	$9M	$30M	$71M	$61M	$43M	$2M	$4M	$7M
Total Liabilities	$170M	$162M	$119M	$62M	$49M	$83M	$90M	$52M	$30M	$35M	$25M	$19M	$18M
Total Debt (Short + Long-Term)	$98M	$100M	$75M	$10M	$1M	$14M	$13M	$26M	$21M	$25M	$18M	$13M	$13M
Total Shareholders' Equity	$339M	$347M	$355M	$377M	$379M	$225M	$235M	$142M	$82M	$47M	$6M	$11M	$18M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KIDS viewer.

Other Companies in MEDICAL DEVICES

IRMD · Iradimed Co — $1 billion
IART · Integra LifeSciences Holdings — $992 million
QDEL · Quidel Corporation — $966 million
AHCO · Adapthealth Corp — $854 million
INMD · InMode Ltd — $810 million
PACB · Pacific Biosciences of California — $810 million
VREX · Varex Imaging Corp — $787 million
CTKB · Cytek Biosciences Inc — $775 million

← KICL All “K” companies KIDZ →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.